1. Specific EGFR Mutations Predict Treatment Outcome of Stage IIIB/IV Patients With Chemotherapy-Naive Non–Small-Cell Lung Cancer Receiving First-Line Gefitinib Monotherapy
   Chih-Hsin Yang et al, 2008, Journal of Clinical Oncology CrossRef